世卫组织批准阿博特的Alinity m MPXV测定作为第一种mpox紧急诊断测试. WHO approves Abbott's Alinity m MPXV assay as first emergency-use diagnostic test for mpox.

世界卫生组织 (WHO) 已批准阿博特实验室的Alinity m MPXV测定作为第一种针对mopox (原名麻疹) 的紧急诊断测试. The World Health Organization (WHO) has approved Abbott Laboratories' Alinity m MPXV assay as the first emergency-use diagnostic test for mpox (formerly monkeypox). 这一PCR测试检测皮肤损伤的血清病毒DNA,目的是在全球疫情爆发时加强检测的可获取性。 This PCR test detects viral DNA from skin lesion swabs and aims to enhance testing accessibility amid a global outbreak. 卫生组织还在评估其他测试,并与制造商接触,以改进诊断工具,特别是针对低收入人口的诊断工具。 WHO is also evaluating additional tests and engaging with manufacturers to improve diagnostic tools, especially for low-income populations.